L2M – Radiant Fluidics

Radiant Fluidics is a Canadian startup working to transform how new cancer therapies are developed by creating automation tools for radiopharmaceutical research. Radiopharmaceuticals are special drugs that combine radioactive materials with targeting compounds to diagnose or treat cancer at the cellular level. However, developing these drugs is currently slow, expensive, and sometimes unsafe due to the limitations of available equipment.

Most research in this space is still done manually, which increases radiation exposure to scientists and limits how often and how much they can safely produce. Alternatively, clinical-grade automation systems can be used to mitigate radiation exposure; however, they are too rigid and expensive for early-stage research. As a result, scientists face a difficult trade-off between flexibility and safety, slowing innovation and delaying access to potentially life-saving treatments.

Radiant Fluidics is addressing this problem with a modular and flexible automation platform designed specifically for research and development. Radiant Fluidics’ system gives researchers more control, improves safety, and allows for faster testing and iteration of new processes.

This internship project will support Radiant Fluidics as it moves from prototype development to early commercialization. The intern will contribute to several core areas: helping the team refine its market strategy, building tools for stakeholder engagement, creating communication and brand materials, and identifying funding and partnership opportunities.

By contributing to the company’s growth and commercialization strategy, this project will help speed up the development of next-generation radiopharmaceuticals and support Canada’s leadership in medical innovation.

Faculty Supervisor:

Carlos Uribe

Student:

Partner:

I-INC Foundation for Business Development

Discipline:

Engineering

Sector:

Professional, scientific and technical services

University:

The University of British Columbia

Program: